NDC 25021-409

eptifibatide

Eptifibatide

eptifibatide is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is Eptifibatide.

Product ID25021-409_130aef4e-e726-4067-8f51-17d0299c5453
NDC25021-409
Product TypeHuman Prescription Drug
Proprietary Nameeptifibatide
Generic NameEptifibatide
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-07-15
Marketing CategoryANDA / ANDA
Application NumberANDA204693
Labeler NameSagent Pharmaceuticals
Substance NameEPTIFIBATIDE
Active Ingredient Strength2 mg/mL
Pharm ClassesDecreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 25021-409-10

1 VIAL in 1 CARTON (25021-409-10) > 10 mL in 1 VIAL
Marketing Start Date2018-07-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 25021-409-10 [25021040910]

eptifibatide INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA204693
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-07-15

NDC 25021-409-51 [25021040951]

eptifibatide INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA204693
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-07-15
Marketing End Date2018-05-11

Drug Details

Active Ingredients

IngredientStrength
EPTIFIBATIDE2 mg/mL

OpenFDA Data

SPL SET ID:a0d18778-0194-461a-a4ea-b2fca5df57c3
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 200349
  • 1736470
  • Pharmacological Class

    • Decreased Platelet Aggregation [PE]
    • Platelet Aggregation Inhibitor [EPC]
    • Decreased Platelet Aggregation [PE]
    • Platelet Aggregation Inhibitor [EPC]

    NDC Crossover Matching brand name "eptifibatide" or generic name "Eptifibatide"

    NDCBrand NameGeneric Name
    0338-9558EptifibatideEptifibatide
    0338-9559EptifibatideEptifibatide
    0703-1165EptifibatideEptifibatide
    14335-070Eptifibatideeptifibatide
    14335-071Eptifibatideeptifibatide
    16729-259EPTIFIBATIDEEptifibatide
    16729-260EPTIFIBATIDEEptifibatide
    17478-902EptifibatideEptifibatide
    17478-903EptifibatideEptifibatide
    25021-408eptifibatideeptifibatide
    25021-409eptifibatideeptifibatide
    52958-040EptifibatideEptifibatide
    52958-402EptifibatideEptifibatide
    70121-1002EptifibatideEptifibatide
    70121-1003EptifibatideEptifibatide
    55150-219EptifibatideEptifibatide
    55150-220EptifibatideEptifibatide
    55150-218EptifibatideEptifibatide
    59651-014EptifibatideEptifibatide
    59651-013EptifibatideEptifibatide
    59651-012EptifibatideEptifibatide
    67457-629EptifibatideEptifibatide
    67457-630EptifibatideEptifibatide
    67457-631EptifibatideEptifibatide
    70436-027EptifibatideEptifibatide
    70436-026EptifibatideEptifibatide
    62147-0601EptifibatideEptifibatide
    62147-0602EptifibatideEptifibatide
    62147-0600EptifibatideEptifibatide
    63739-970EptifibatideEptifibatide
    63739-923EptifibatideEptifibatide
    63739-911EptifibatideEptifibatide
    70436-163EptifibatideEptifibatide
    72078-025EptifibatideEptifibatide
    72078-027EptifibatideEptifibatide
    72078-026EptifibatideEptifibatide
    70436-162EptifibatideEptifibatide
    0085-1136IntegrilinEptifibatide
    0085-1177IntegrilinEptifibatide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.